FDA warns Ohio over execution drug; GSK gets permit for Memphis facility;

> The FDA has sent a letter to the Ohio Department of Rehabilitation and Correction warning that it must get FDA approval if it is thinking about importing a drug for executions. Story

> The FDA is warning providers not to use compounded drugs stored in Becton Dickinson ($BDX) 3 mL and 5 mL syringes because they are not approved as storage devices and drugs may be subpotent. Announcement

> GlaxoSmithKline ($GSK) has gotten a building permit for $2 million in modifications for a facility in Memphis, TN. Report

Suggested Articles

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back. 

The lawmakers question Kodak's fitness for such a major pharma manufacturing deal, as well as suspicious stock transactions by company leadership.

AZ's China COVID-19 vaccine deal comes after supply agreements with the U.S., the U.K., EU and Brazil, as well as licensing pacts in India and Japan.